07.27.07
$1.8 Billion
Key Executives:
Bret W. Wise, Chairman, CEO and President
Christopher T, Clark, Exec. VP and COO
William R. Jellison, CFO and Senior VP
Rachel P. McKinney, Sr. VP, Global Human Resources
James G. Mosch, Sr. VP
Bob Size, Sr. VP
No. of Employees: 9,400
World Headquarters: York, PA
Reorganization is the name of the game for Dentsply, which had a turnaround year in 2006. After experiencing a net loss in 2005, the dental manufacturer set its sight on business collaborations and restructuring to enhance growth.
It will be interesting to see where the company is headed in the future, as Dentsply’s longtime chairman and CEO, Gary Kunkle, retired at the end of 2006. During his 10-year tenure, sales nearly tripled. Bret Wise, former president and COO of Dentsply, assumed the role of chairman and CEO on Jan. 1.
For 2006, net sales totaled $1.8 billion, a 5.6% rise from $1.72 billion reported in 2005. Net income was reported at $223.7 million. The overall growth in net sales was characterized by steady but unremarkable growth in each quarter of the fiscal year, ended Dec. 31, with percentage increases in the 4.8% to 6.2% range.
With a pivotal focus on specialty dental products, Dentsply has established itself in 22 nations on six continents. The US market contributed 42% of sales in 2006, with Europe following at 38%. Japan added 4% to sales and other parts of the world offered 16%.
Dentsply’s specialty product line—consisting of orthodontic, endodontic and dental implant products and materials—contributed the bulk of sales in 2006, at 40% of the share. Dental laboratory equipment added 22% to overall sales, and consumables (eg, impression and restorative materials, anesthetics, bonding agents, etc.) contributed 38%.
According to the company, Dentsply introduces approximately 25 new products each year. Among 2006 product launches were the Cercon Eye, a tabletop scanner for producing digital images of dental prosthetic devices; In-Ovation C, an orthodontic product that uses clear ceramic brackets with arch wire; Radica, a composite system in prosthetics; and XP Bond, which adheres light-cured restorative materials to enamel and dentine without priming.
In terms of the company’s other activities, the past year has been marked by major restructuring efforts as Dentsply continues to streamline operations and pursue growth.
In 2006, the US sales force for the consumables division was moved under a single sales organization, referred to as Dentsply North America. The company said this entity has become the largest combined sales force in the market and offers lead sharing, cross marketing and more efficient distribution.
In August, Dentsply sold its injectable anesthetic facility and equipment to Pierrel, a pharmaceutical contract manufacturing and drug development company based in Milan, Italy, for $19.5 million. As a result, Dentsply unveiled plans to outsource production of its injectable anesthetic line and partner with industry leaders in the anesthetic field.
One of Dentsply’s most significant moves in 2006 occurred when the company decided to consolidate its US distribution base during the third quarter. With this move, the company now partners with 28 key dealers that formerly were responsible for more than 90% of sales and growth. According to Dentsply officials, this move was made to form closer relationships with these dealers while improving collaboration.
Finally, toward the end of 2006, Dentsply combined its US implant and endodontic divisions into one unit.
Acquisitions also figured into the company’s long-term strategy. Last year, Dentsply acquired a 40% interest in Materialise Dental N.V. for its digital dentistry capabilities. In addition, Wise noted in the 2006 annual report that previous acquisitions of European company GAC SA and US-based Raintree Essix and Glenroe Technologies contributed strong growth for Dentsply that year.
Dentsply continues to embark on continued success, with first-quarter results for 2007 reflecting substantial financial growth. Net sales were up 9.7% to $472.9 million, an increase that has been attributed to the sale of specialty products such as implants, orthodontic products and the company’s all-ceramic Cercon products. All product lines experienced double-digit sales growth in the quarter ended March 31. Net income was reported at $58.5 million, up 22.6%.
Key Executives:
Bret W. Wise, Chairman, CEO and President
Christopher T, Clark, Exec. VP and COO
William R. Jellison, CFO and Senior VP
Rachel P. McKinney, Sr. VP, Global Human Resources
James G. Mosch, Sr. VP
Bob Size, Sr. VP
No. of Employees: 9,400
World Headquarters: York, PA
Reorganization is the name of the game for Dentsply, which had a turnaround year in 2006. After experiencing a net loss in 2005, the dental manufacturer set its sight on business collaborations and restructuring to enhance growth.
It will be interesting to see where the company is headed in the future, as Dentsply’s longtime chairman and CEO, Gary Kunkle, retired at the end of 2006. During his 10-year tenure, sales nearly tripled. Bret Wise, former president and COO of Dentsply, assumed the role of chairman and CEO on Jan. 1.
For 2006, net sales totaled $1.8 billion, a 5.6% rise from $1.72 billion reported in 2005. Net income was reported at $223.7 million. The overall growth in net sales was characterized by steady but unremarkable growth in each quarter of the fiscal year, ended Dec. 31, with percentage increases in the 4.8% to 6.2% range.
With a pivotal focus on specialty dental products, Dentsply has established itself in 22 nations on six continents. The US market contributed 42% of sales in 2006, with Europe following at 38%. Japan added 4% to sales and other parts of the world offered 16%.
Dentsply’s specialty product line—consisting of orthodontic, endodontic and dental implant products and materials—contributed the bulk of sales in 2006, at 40% of the share. Dental laboratory equipment added 22% to overall sales, and consumables (eg, impression and restorative materials, anesthetics, bonding agents, etc.) contributed 38%.
According to the company, Dentsply introduces approximately 25 new products each year. Among 2006 product launches were the Cercon Eye, a tabletop scanner for producing digital images of dental prosthetic devices; In-Ovation C, an orthodontic product that uses clear ceramic brackets with arch wire; Radica, a composite system in prosthetics; and XP Bond, which adheres light-cured restorative materials to enamel and dentine without priming.
In terms of the company’s other activities, the past year has been marked by major restructuring efforts as Dentsply continues to streamline operations and pursue growth.
In 2006, the US sales force for the consumables division was moved under a single sales organization, referred to as Dentsply North America. The company said this entity has become the largest combined sales force in the market and offers lead sharing, cross marketing and more efficient distribution.
In August, Dentsply sold its injectable anesthetic facility and equipment to Pierrel, a pharmaceutical contract manufacturing and drug development company based in Milan, Italy, for $19.5 million. As a result, Dentsply unveiled plans to outsource production of its injectable anesthetic line and partner with industry leaders in the anesthetic field.
One of Dentsply’s most significant moves in 2006 occurred when the company decided to consolidate its US distribution base during the third quarter. With this move, the company now partners with 28 key dealers that formerly were responsible for more than 90% of sales and growth. According to Dentsply officials, this move was made to form closer relationships with these dealers while improving collaboration.
Finally, toward the end of 2006, Dentsply combined its US implant and endodontic divisions into one unit.
Acquisitions also figured into the company’s long-term strategy. Last year, Dentsply acquired a 40% interest in Materialise Dental N.V. for its digital dentistry capabilities. In addition, Wise noted in the 2006 annual report that previous acquisitions of European company GAC SA and US-based Raintree Essix and Glenroe Technologies contributed strong growth for Dentsply that year.
Dentsply continues to embark on continued success, with first-quarter results for 2007 reflecting substantial financial growth. Net sales were up 9.7% to $472.9 million, an increase that has been attributed to the sale of specialty products such as implants, orthodontic products and the company’s all-ceramic Cercon products. All product lines experienced double-digit sales growth in the quarter ended March 31. Net income was reported at $58.5 million, up 22.6%.